LOCALIZATION OF INTERLEUKIN-1 IN HUMAN CHOLESTEATOMA

被引:40
作者
AHN, JM [1 ]
HUANG, CC [1 ]
ABRAMSON, M [1 ]
机构
[1] COLUMBIA UNIV COLL PHYS & SURG,DEPT OTOLARYNGOL,NEW YORK,NY 10032
关键词
bone resorption; cholesteatoma; interleukin-1; keratinocytes;
D O I
10.1016/0196-0709(90)90001-C
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Recent studies by other investigators have shown that interleukin-1 (IL-1) promotes bone resorption by stimulating various cells. Interleukin-1 not only stimulates collagenase production by fibroblasts and macrophages, but also acts as an osteoclast-activating factor. In this study, IL-1 was localized in human cholesteatoma tissues using both immunoperoxidase and immunofluorescent-staining methods with specific monoclonal antibodies. Highly concentrated IL-1 was found in the epithelial layer and granulation tissue. More specifically, intense staining was seen in basal and spinous cells of the epithelial layer, and in fibroblasts and macrophages of the granulation layer. We also located IL-1 in the normal external ear canal skin; however, the intensity of the staining in the cholesteatoma epithelium was found to be stronger. The presence of IL-1 in the epithelial layer and granulation tissue of the cholesteatoma suggests that IL-1 from the stimulated keratinocytes of the cholesteatoma could be one factor responsible for the markedly increased bone resorption observed in cholesteatoma patients. © 1990.
引用
收藏
页码:71 / 77
页数:7
相关论文
共 17 条
  • [1] Maury, Interleukin-1 and the pathogenesis of inflammatory diseases, Acta Med Scand, 220, pp. 291-294, (1986)
  • [2] Dewhirst, Stashenko, Mole, Et al., Purification and partial sequence of human osteoclast-activating factor: Identity with interleukin-1 beta, J Immunol, 135, pp. 2562-2568, (1985)
  • [3] Kampschmidt, Upchurch, Neutrophil release after injections of endotoxin or leukocytic endogenous mediator into rats, J Reticuloendothel Soc, 28, pp. 191-201, (1980)
  • [4] Prostlethwaite, Lachman, Mainardi, Et al., Interleukin-1 stimulation of collagenase production by cultured fibroblasts, Journal of Experimental Medicine, 157, pp. 801-806, (1983)
  • [5] Gahring, Buckley, Daynes, Presence of epidermal cell-derived thymocyte-activating factor/interleukin-1 in normal human stratum corneum, J Clin Invest, 76, pp. 1585-1591, (1985)
  • [6] Luger, Oppenheim, Characteristics of interleukin-1 and epidermal cell-derived thymocyte-activating factor, Advances in Inflammation Research (5), pp. 1-25, (1983)
  • [7] Kupper, Ballard, Chua, Et al., Human keratinocytes contain mRNA indistinguishable from monocyte interleukin-1 alpha and beta mRNA. Keratinocyte epidermal cell-derived thymocyte-activating factor is identical to interleukin-1, J Exp Med, 164, pp. 2095-2100, (1986)
  • [8] Sade, Halevy, The aetiology of bone destruction in chronic otitis media, J Laryngol Otol, 88, pp. 139-143, (1974)
  • [9] Thomsen, Tos, Nielsen, Et al., Bone destruction in inflammatory disease of the ear, Proceedings of the Second International Conference on Cholesteatoma and Mastoid Surgery, pp. 397-411, (1982)
  • [10] Tos, Pathology of the ossicular chain in various chronic middle ear disease, J Otolaryngol, 93, pp. 769-780, (1979)